This move is archived. Current quotes and coverage live on the stock page.
Get HEM alerts:
Hemostemix Inc's stock has taken a significant hit, dropping over 9% in the last trading session.
In the latest trading session, Hemostemix Inc (HEM.V) experienced a sharp decline, closing down 9.09% at CA$0.05. This drop raises concerns among investors about the company's current standing and future prospects.
Advertisement
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$14.80M
52W high
$0.13
52W low
$0.04
1W change
-6.67%
Beta
0.67
Analyst Price Targets
Based on analyst covering HEM · as of Sep 17, 2026
Wall Street analysts forecast HEM stock price to rise 1271.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.96
+1271.4% Upside
Current Price
C$0.07
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
105.6%
Annualized
90-Day Vol
116.8%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$0.09
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.08 | C$0.06 – C$0.11 |
| 60 trading days | C$0.08 | C$0.05 – C$0.14 |
| 90 trading days | C$0.09 | C$0.05 – C$0.17 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should closely monitor Hemostemix's financial health and market developments, as the recent price drop may indicate underlying issues that could impact future performance.
HEM.V down 9.09% in one day
The market cap has fallen to CA$10.25 million, reflecting investor concerns about Hemostemix's financial viability.
Bull case
If Hemostemix can effectively use its recent private placements to fund key initiatives, it might regain investor confidence and stabilize its stock price.
Bear case
On the other hand, continued losses and a lack of positive news could lead to further declines, putting investor capital and the company's market position at risk.
Recent Performance Overview
Advertisement
Hemostemix Inc's stock fell sharply by 9.09%, closing at CA$0.05. This decline is notable given the company's recent attempts to raise capital through private placements, which may not have instilled the confidence investors were hoping for.
Market Reactions and Future Outlook
The market's reaction to Hemostemix's performance shows a cautious sentiment among investors. With a market cap now at CA$10.25 million, stakeholders will be watching closely for any developments that could either stabilize or further destabilize the stock.
What Investors Should Watch For
Investors should keep an eye on Hemostemix's upcoming announcements and financial reports. The company's ability to effectively utilize funds from recent private placements could be crucial in shaping its recovery trajectory.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
